Nouscom announces leading publication revealing an immune mechanism of action driving anti-tumor activity of adenovirus vectored vaccines and anti-PD1 immunotherapy Research paper published in Science Translational Medicine by Nouscom and the Armenise-Harvard Laboratory of Immunoregulation at IIGM led by Luigia.
/PRNewswire/ Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications.